Literature DB >> 22866138

Increased telomerase activity and hTERT expression in human salivary gland carcinomas.

Hideo Shigeishi1, Masaru Sugiyama, Hidetoshi Tahara, Shigehiro Ono, Ujjal Kumar Bhawal, Masaya Okura, Mikihiko Kogo, Masanori Shinohara, Masanobu Shindoh, Satoru Shintani, Hiroyuki Hamakawa, Takashi Takata, Nobuyuki Kamata.   

Abstract

Approximately 85% of human malignant tumors express increased levels of telomerase. The marked association of telomerase activity with malignant tissue provides strong evidence that telomerase activity is a significant marker for the diagnosis of cancer. In this study, telomerase activity was examined in 12 benign salivary gland tumors (8 pleomorphic adenomas and 4 adenolymphomas), 24 malignant tumors (15 mucoepidermoid carcinomas, 6 adenoid cystic carcinomas and 3 acinic cell carcinomas) and 6 non-neoplastic salivary glands. The mRNA expression of the human telomerase reverse transcriptase (hTERT) and additional telomerase‑associated proteins (hTEP1, p23, Hsp90 and dyskerin) was also examined. Of the 24 malignant tumors, 15 revealed strong telomerase activity. The non-neoplastic salivary glands appeared to have a negative telomerase expression. Furthermore, telomerase activity was significantly higher in high-grade mucoepidermoid carcinomas compared to low‑grade ones (Student's t-test, p<0.05). A significant correlation was found between telomerase activity and mRNA expression of hTERT in 15 cases, including non-neoplastic salivary glands and tumors (Spearman's rank correlation test, p<0.05). Furthermore, a significant correlation was found between telomerase activity and mRNA expression of EGFR (Spearman's rank correlation test, p<0.001). The results suggest that not only hTERT, but also EGFR play a significant role in the activation of telomerase. In conclusion, the results suggest that telomerase activity and hTERT/EGFR mRNA expression are useful markers for the detection of malignant cells in salivary gland carcinomas. Moreover, our results indicated that telomerase activity determines the degree of malignancy of mucoepidermoid carcinoma.

Entities:  

Year:  2011        PMID: 22866138      PMCID: PMC3408017          DOI: 10.3892/ol.2011.354

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Telomerase activity in oral cancer.

Authors:  Y Miyoshi; K Tsukinoki; T Imaizumi; Y Yamada; T Ishizaki; Y Watanabe; Y Sasakura; Y Lin; M Hosaka; Y Kubota
Journal:  Oral Oncol       Date:  1999-05       Impact factor: 5.337

Review 2.  Telomerase and cancer: revisiting the telomere hypothesis.

Authors:  C Autexier; C W Greider
Journal:  Trends Biochem Sci       Date:  1996-10       Impact factor: 13.807

3.  Detection of telomerase activity in oral lesions.

Authors:  T Sumida; K Sogawa; H Hamakawa; A Sugita; H Tanioka; N Ueda
Journal:  J Oral Pathol Med       Date:  1998-03       Impact factor: 4.253

Review 4.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

5.  EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations.

Authors:  Rohit Bhargava; William L Gerald; Allan R Li; Qiulu Pan; Priti Lal; Marc Ladanyi; Beiyun Chen
Journal:  Mod Pathol       Date:  2005-08       Impact factor: 7.842

6.  EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis.

Authors:  Steffen Heeg; Nina Hirt; Angela Queisser; Hannah Schmieg; Michaela Thaler; Heike Kunert; Michael Quante; Gitta Goessel; Alexander von Werder; Jan Harder; Roderick Beijersbergen; Hubert E Blum; Hiroshi Nakagawa; Oliver G Opitz
Journal:  Cancer Sci       Date:  2010-12-12       Impact factor: 6.716

7.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 8.  Epidermal growth factor receptor biology (IMC-C225).

Authors:  E S Kim; F R Khuri; R S Herbst
Journal:  Curr Opin Oncol       Date:  2001-11       Impact factor: 3.645

9.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer.

Authors:  M Takakura; S Kyo; T Kanaya; M Tanaka; M Inoue
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

10.  Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas.

Authors:  J Nakayama; H Tahara; E Tahara; M Saito; K Ito; H Nakamura; T Nakanishi; E Tahara; T Ide; F Ishikawa
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

View more
  6 in total

1.  Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.

Authors:  Eric S Kim; Yuanqing Ye; Ara A Vaporciyan; Jinliang Xing; Maosheng Huang; Jian Gu; Jack A Roth; Scott M Lippman; Xifeng Wu
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

2.  Clinicopathological analysis of salivary gland carcinomas and literature review.

Authors:  Hideo Shigeishi; Kouji Ohta; Gaku Okui; Sayaka Seino; Miho Hashikata; Kazuhiro Yamamoto; Yoko Ishida; Kazuki Sasaki; Takako Naruse; Mohammad Zeshaan Rahman; Ryo Uetsuki; Akiko Nimiya; Shigehiro Ono; Hiroshi Shimasue; Koichiro Higashikawa; Masaru Sugiyama; Masaaki Takechi
Journal:  Mol Clin Oncol       Date:  2014-10-09

Review 3.  Treating Cancer by Targeting Telomeres and Telomerase.

Authors:  Marko Ivancich; Zachary Schrank; Luke Wojdyla; Brandon Leviskas; Adijan Kuckovic; Ankita Sanjali; Neelu Puri
Journal:  Antioxidants (Basel)       Date:  2017-02-19

4.  Myoepithelial Carcinoma Ex-Pleomorphic Adenoma: A Rare Pathology Misdiagnosed as Pleomorphic Adenoma; With a Novel TERT Promoter Mutation and High PD-L1 Expression.

Authors:  Christopher Cormier; Shweta Agarwal
Journal:  Head Neck Pathol       Date:  2021-06-14

5.  hTERT promoter activity identifies osteosarcoma cells with increased EMT characteristics.

Authors:  Ling Yu; Shiqing Liu; Weichun Guo; Chun Zhang; Bo Zhang; Huichao Yan; Zheng Wu
Journal:  Oncol Lett       Date:  2013-11-19       Impact factor: 2.967

6.  Immunohistochemical evaluation of salivary gland tumors differentiation and proliferation by using calponin and telomerase.

Authors:  Srwsht Saeed Abdulrahman; Dena Nadhim Mohammad; Marwa Abdul-Salam Hamied; Mardin Othman Abdulqadir
Journal:  Saudi Dent J       Date:  2018-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.